ArticleNature metabolism2024
Subcellular NAD
Abstract read
In one paragraph
Article in Nature metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Remodeling of mitochondrial dynamics by metabolic pathways couples to oncogenic growth inScience advances · 2026Article
- Glutaminolysis Blockade-Empowered Bimodal Nanodepot for Spatially Complementary Sono-Thermal Ablation via PANoptosis and STING Activation Against Large Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Mitochondrial dysfunction drives metabolic reprogramming in Gitelman syndrome: insights from proteomics and isogenic modeling.Human genetics · 2026Article
- The lithium-magnesium-zinc axis under stress: regulation of N-glycosylation-linked proteostasis and Alzheimer's disease.Inflammopharmacology · 2026Article
- SLC25A51 and mitochondrial NAD⁺ transport in acute myeloid leukemia: mechanisms, therapeutic potential, and translational perspectives.Human cell · 2026Review
- Overexpression of NMNAT3 suppresses melanoma progression by reprogramming NAD⁺ metabolism.Translational oncology · 2026Article
- Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers.MedComm · 2026Review
- Article
- Placental nicotinamide adenine dinucleotide modulates the timing of labor.Science (New York, N.Y.) · 2026Article
- Whole-blood NADNature metabolism · 2026Article
- Molecular Engineering of Nicotinamide Riboside Kinase and Process Optimization for Efficient Nicotinamide Mononucleotide Production.Foods (Basel, Switzerland) · 2026Article
- Review
- The Expanding Landscape of ADP-Ribosylation: Protein, DNA, RNA, and Mitochondrial Regulation.Chemical research in toxicology · 2026Review
- Hydrogen Sulfide Protects Against Cerebral Ischemia-Reperfusion Injury in Rats via S-Sulfhydrating NAMPT to Enhance Mitochondrial Function and Autophagy in Cerebrovascular Endothelial Cells.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Aging Triggers an Intestinal Energy Crisis and HDL3 Deficiency Disrupting Gut-Liver Axis Homeostasis.Aging cell · 2026Article
- Reduced Versus Oxidized NADFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
- A step-by-step guide to performing cancer metabolism research using custom-made media.Life science alliance · 2026Article
- Mitochondrial NMNAT3 reduces amyloid aggregates inMitochondrial communications · 2026Article
- Novel applications of SIRT1 in Chronic Kidney Disease.Frontiers in medicine · 2026Review
- Effects of aging and anti-aging dietary restriction on regulators of the [NADPH]/[NADPFree radical biology & medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Lena E Høyland *Department of Biomedicine, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-7189-780X
Magali R VanLinden *Department of Biomedicine, University of Bergen, Bergen, Norway.
Marc Niere *Department of Biomedicine, University of Bergen, Bergen, Norway.
Øyvind StrømlandDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Suraj SharmaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Jörn DietzeDepartment of Arctic and Marine Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Ingvill TolåsDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Eva LucenaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Ersilia BifulcoDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Lars J SverkeliDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Camila Cimadamore-WertheinDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Hanan AshrafiDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Kjellfrid F HaukanesDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Barbara van der HoevenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Christian DölleNeuro-SysMed Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway.ORCID http://orcid.org/0000-0003-2427-8130
Cédric DavidsenDepartment of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Ina K N PettersenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Karl J TronstadDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Svein A MjøsDepartment of Chemistry, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-5948-7373
Faisal HayatMitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
Mikhail V MakarovMitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
Marie E MigaudMitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.ORCID http://orcid.org/0000-0002-9626-2405
Ines HeilandNeuro-SysMed Center, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Mathias ZieglerDepartment of Biomedicine, University of Bergen, Bergen, Norway. Mathias.Ziegler@uib.no.ORCID http://orcid.org/0000-0001-6961-2396
Funding
Norges Forskningsråd (Research Council of Norway) 315849Norges Forskningsråd (Research Council of Norway) 325172Oregon Health & Science University | Oregon Clinical and Translational Research Institute (Oregon Clinical & Translational Research Institute) NNX16AO69A
Abstract
The coenzyme NAD
Indexed as
MitochondriaNADCytosolHumansNicotinamide-Nucleotide AdenylyltransferasePoly(ADP-ribose) PolymerasesNADNicotinamide-Nucleotide AdenylyltransferaseNMNAT3 protein, humanPoly(ADP-ribose) Polymerases
Identifiers
PMID
39702414What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.